Smart Money Alert

Suven Life Sciences Limited

DecreasedQuarterly

SUVENHealthcare Research, Analytics & TechnologyMarket Cap₹9K Cr

Stake

1.13% → 1.00%

Abakkus Mutual Fund

Mutual Fund

The move

Abakkus Mutual Fund decreased its stake in Suven Life Sciences from 1.13% to 1.00%, selling 168,636 shares. The value of the sold shares is approximately ₹5.49 Cr, calculated at the last closing price of ₹325.90 apiece.

About Suven Life Sciences Limited

Visit stock

A clinical-stage biopharmaceutical company engaged in the acquisition, development, and commercialization of novel therapeutics for treating neurodegenerative disorders. Suven Life Sciences operates across research, analytics, and technology platforms to advance its pipeline of investigational drugs targeting diseases affecting the nervous system. The company focuses on bringing innovative treatment solutions to patients suffering from neurological conditions through rigorous clinical development processes.

About Abakkus Mutual Fund

Visit investor

AMC arm of Abakkus Asset Manager, founded by Sunil Singhania, former CIO of Reliance Mutual Fund who oversaw the equity book when it was India's largest. Launched its maiden Flexi Cap Fund in December 2025, raising Rs 2,468 crore in the NFO alone, and crossed Rs 5,000 crore within months. The MF licence brings Sunil Singhania's quality small and midcap compounding philosophy to all retail investors.

Get the next move the moment it happens.

Follow Abakkus Mutual Fund and Suven Life Sciences Limited on WhaleWatch, alongside 300+ top investors, funds and FPIs. The newest moves are waiting for you inside.

Explore

Suven Life Sciences Limited shareholders Abakkus Mutual Fund's portfolio All investors All stocks

🤖 We track their every move, post, interview and article. Obsessively.

⚡ Every move reaches your feed in minutes, while it still carries an edge

📊 Stake changes, bulk deals and insider trades, all tracked in one place

📰 A two-minute morning brief, so you start the day already ahead

More moves in Suven Life Sciences Limited

Quant Mutual FundExited

Quant Mutual Fund has dropped from Suven Life Sciences Limited's disclosed shareholder list after previously holding 1.78 percent, indicating either a complete exit or a reduction of its stake to below the 1 percent reporting requirement.

19 Jul 2026

Jasti Property and Equity Holdings Private LimitedIncreased

Jasti Property and Equity Holdings Private Limited increased its stake in Suven Life Sciences from 65.40% to 69.57% by acquiring 3,17,68,764 shares for ₹437.58 Cr at ₹137.74 apiece through a preferential allotment.